Brief: Therapeuticsmd Says Received Nasdaq Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule
13/01/2023 24:00
Jan 12 (Reuters) - TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD INC - RECEIVED NASDAQ NOTICE OF DELISTING
OR
FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD ON
JANUARY 6
Further company coverage: TXMD.O
((reuters.briefs@thomsonreuters.com;))
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract